Resources
All About Angel Investors
All About Venture Capitalists
Business Funding Resources
Small Business Funding
Startup Capital Needs
Business Plans & Proposals
Entrepreneur - New Business
Resources
Resources
Predictive Medicine Company Seeking $5 Million in Growth Capital
Posted by: Brandon Colby on 7/14/2010 9:05:26 PM
Funding Needed:
Above $1mil 		Category:
Healthcare & Medical / Pharma 		Website :
Please login to view.
Location :
Los Angeles, California, USA 		Viewed : 207 times
Favorited : 0 times 		Share
Description:
We are the world’s first predictive medicine company and seeking $5 million in early stage business funding to grow our business. The goal is to become a leader in the $232 billion personalized medicine market, which is projected to grow by 11 percent annually according to Pricewaterhouse Coopers LLP, by empowering health care professionals with access to genetic technology so that they can efficiently integrate genetic screening into their practice and provide cutting-edge predictive medicine services to their patient population. We use highly advanced, patent-pending genetic screening technology to not only inform you of your risk for hundreds of diseases, but also to provide you with personalized information about what exactly you can do with that information to protect yourself against any diseases you are found to be predisposed to. We enable health care professionals to be able to proactively prevent disease before it ever manifests.

Our focus to date has been on developing the Nexus platform comprised of the Nexus gene chip, a first-of-its-kind proprietary information technology system and extensive intellectual property that comprise the backbone of the company and provides us with a significant, sustainable competitive advantage. The Nexus platform includes a number of patent-pending technologies designed to effectively analyze very large amounts of genetic information and convey the results to healthcare professionals in an easy-to-understand, straightforward report. The end result is our next-generation genetic reports that are clear, understandable and fully personalized. After close to five years of development we are preparing to roll out our first product at the end of the summer of 2010.

Our technologies also enable full genome clinical analysis of full genome sequencing data. With projections of almost one billion genomes being sequenced by 2020, the market potential for the unique and proprietary genetic analysis services provided by us will be instrumental in providing the entire health care industry with useful analysis of all of that data. By 2015 we expect to have over 100 genetic screening panels available that will cover all aspects of life and medicine, including preconception, prenatal, newborn, childhood, and adult genetic screening.

We are looking for funding from angel, venture capital, private equity, and corporate investors. Funds raised will be used for growth capital, allowing us to build out and market our product offerings while maintaining our technological advantage.

 Digg It    Stumble It    Deli.icio.us
Respond
You must be a member to respond to this post. If you are a member , please login to respond.